Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor

IL-6 modulates immune responses and is essential for timely wound healing. As the functions mediated by IL-6 require binding to its specific receptor, IL-6Rα, it was expected that mice lacking IL-6Rα would have the same phenotype as IL-6–deficient mice. However, although IL-6Rα–deficient mice share many of the inflammatory deficits seen in IL-6–deficient mice, they do not display the delay in wound healing. Surprisingly, mice with a combined deficit of IL-6 and IL-6Rα, or IL-6–deficient mice treated with an IL-6Rα–blocking Ab, showed improved wound healing relative to mice with IL-6 deficiency, indicating that the absence of the receptor contributed to the restoration of timely wound healing, rather than promiscuity of IL-6 with an alternate receptor. Wounds in mice lacking IL-6 showed delays in macrophage infiltration, fibrin clearance, and wound contraction that were not seen in mice lacking IL-6Rα alone and were greatly reduced in mice with a combined deficit of IL-6 and IL-6Rα. MAPK activation-loop phosphorylation was elevated in wounds of IL-6Rα–deficient mice, and treatment of wounds in these mice with the MEK inhibitor U0126 resulted in a delay in wound healing suggesting that aberrant ERK activation may contribute to improved healing. These findings underscore a deeper complexity for IL-6Rα function in inflammation than has been recognized previously.

[1]  W. Ferlin,et al.  The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling1 , 2009, The Journal of Immunology.

[2]  C. Riley,et al.  Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas , 2008, British Journal of Cancer.

[3]  Philip M Murphy,et al.  SOCS3 negatively regulates the gp130-STAT3 pathway in mouse skin wound healing. , 2008, The Journal of investigative dermatology.

[4]  J. Scheller,et al.  Transgenic blockade of interleukin 6 transsignaling abrogates inflammation. , 2008, Blood.

[5]  C. Fielding,et al.  Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. , 2007, Blood.

[6]  R. Gallucci,et al.  Interleukin‐6 (IL‐6) modulates migration and matrix metalloproteinase function in dermal fibroblasts from IL‐6KO mice , 2007, The British journal of dermatology.

[7]  J. Scheller,et al.  Interleukin‐6 biology is coordinated by membrane‐bound and soluble receptors: role in inflammation and cancer , 2006, Journal of leukocyte biology.

[8]  Serge Haan,et al.  Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation. , 2005, Cellular signalling.

[9]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[10]  J. Scheller,et al.  IL-6 transsignaling: the in vivo consequences. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  A. Ullrich,et al.  Mammary Gland Remodeling Depends on gp130 Signaling through Stat3 and MAPK* , 2004, Journal of Biological Chemistry.

[12]  M. Schwaninger,et al.  The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice , 2003, Behavioural Brain Research.

[13]  Stefan Rose-John,et al.  Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation , 2003 .

[14]  N. Mukaida,et al.  Essential involvement of IL‐6 in the skin wound‐healing process as evidenced by delayed wound healing in IL‐6‐deficient mice , 2003, Journal of leukocyte biology.

[15]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[16]  S. Rose-John,et al.  Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited , 2003, The Journal of Biological Chemistry.

[17]  P. Igaz,et al.  Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cells. , 2002, Immunology letters.

[18]  H. Ahorn,et al.  N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth , 2002, Oncogene.

[19]  T. Glant,et al.  Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human Osteoblasts* , 2002, The Journal of Biological Chemistry.

[20]  J. D. Vos,et al.  Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells , 2002, Oncogene.

[21]  R. Gilmont,et al.  MAP kinase pathways involving hsp27 regulate fibroblast-mediated wound contraction. , 2002, The Journal of surgical research.

[22]  C. Begley,et al.  An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells , 2002, Oncogene.

[23]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[24]  M. Luster,et al.  Impaired cutaneous wound healing in interleukin‐6‐deficient and immunosuppressed mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  J. Heath,et al.  Receptor recognition by gp130 cytokines , 2000, The EMBO journal.

[26]  H. Baumann,et al.  Dual Signaling Role of the Protein Tyrosine Phosphatase SHP-2 in Regulating Expression of Acute-Phase Plasma Proteins by Interleukin-6 Cytokine Receptors in Hepatic Cells , 1999, Molecular and Cellular Biology.

[27]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[28]  H. Baumann,et al.  The STAT3-independent Signaling Pathway by Glycoprotein 130 in Hepatic Cells* , 1999, The Journal of Biological Chemistry.

[29]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[30]  Simon A. Jones,et al.  Shedding of the soluble IL‐6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP‐1 cells , 1998, European journal of immunology.

[31]  P. Angrand,et al.  Improved properties of FLP recombinase evolved by cycling mutagenesis , 1998, Nature Biotechnology.

[32]  L. Moldawer,et al.  Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis. , 1998, Cytokine.

[33]  H. Kung,et al.  Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells , 1998, Nature.

[34]  A. Ben-nun,et al.  Interleukin‐6 functions in autoimmune encephalomyelitis: a study in gene‐targeted mice , 1998, European journal of immunology.

[35]  T. Bugge,et al.  Ligneous conjunctivitis in plasminogen-deficient mice. , 1998, Blood.

[36]  W. Schiemann,et al.  Box 3-independent Signaling Mechanisms Are Involved in Leukemia Inhibitory Factor Receptor α- and gp130-mediated Stimulation of Mitogen-activated Protein Kinase , 1997, The Journal of Biological Chemistry.

[37]  M. Hibi,et al.  Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin‐6 , 1997, FEBS letters.

[38]  E. Furth,et al.  Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.

[39]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[40]  E. Wolf,et al.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.

[41]  M. Marshall,et al.  Interleukin-11 Induces Complex Formation of Grb2, Fyn, and JAK2 in 3T3L1 Cells (*) , 1995, The Journal of Biological Chemistry.

[42]  J. Darnell,et al.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors , 1995, Science.

[43]  G. Fantuzzi,et al.  Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.

[44]  M. Waki,et al.  Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism , 1994, European journal of immunology.

[45]  P. Heinrich,et al.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. , 1994, Journal of immunology.

[46]  A. Dunn,et al.  Functional and biochemical association of Hck with the LIF/IL‐6 receptor signal transducing subunit gp130 in embryonic stem cells. , 1994, The EMBO journal.

[47]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[48]  G. Ciliberto,et al.  Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. , 1994, The EMBO journal.

[49]  G. Yancopoulos,et al.  Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. , 1994, Science.

[50]  C. Schindler,et al.  Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. , 1994, Science.

[51]  K. Yasukawa,et al.  IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.

[52]  G. Fuller,et al.  Ciliary neurotrophic factor regulates fibrinogen gene expression in hepatocytes by binding to the interleukin-6 receptor. , 1993, Biochemical and biophysical research communications.

[53]  P. Heinrich,et al.  Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level , 1993, Molecular and cellular biology.

[54]  P. Heinrich,et al.  Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor. , 1992, Biochemical and biophysical research communications.

[55]  P. Heinrich,et al.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. , 1992, Journal of immunology.

[56]  S. Rosenberg,et al.  Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.

[57]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.

[58]  R. Ross,et al.  The neutrophilic leukocyte in wound repair a study with antineutrophil serum. , 1972, The Journal of clinical investigation.

[59]  B. Jenkins,et al.  Acquiring signalling specificity from the cytokine receptor gp130. , 2004, Trends in genetics : TIG.

[60]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[61]  N. Hynes,et al.  Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. , 2001, Cancer research.

[62]  S. Tóth,et al.  Soluble interleukin-6 receptor in plasma and in lymphocyte culture supernatants of healthy individuals and patients with systemic lupus erythematosus and rheumatoid arthritis. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[63]  T. Hirano,et al.  Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses. , 2000, Immunity.

[64]  J. Gauldie,et al.  Regulation of IL-6 and the hepatic IL-6 receptor in acute inflammation in vivo. , 1993, Cytokine.

[65]  M. B. Grivell,et al.  Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions. , 1992, Life sciences.

[66]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.